on 04-21-2023 06:10 AM
Knowing the genome packaging efficiency during adeno-associated virus (AAV) manufacturing is a crucial step toward the successful clinical application of next-generation biotherapeutics.
In recent years, recombinant AAV production has been steadily optimized to yield high genome packaging efficiency; but empty capsids often remain an undesired byproduct during manufacturing. Additionally, some evidence shows immune reactions caused by empty capsids. Therefore, it’s important to know the precise amount of correctly filled AAV capsids in order to determine the correct dosage required for treatment.
For all these reasons, it’s extremely important to have analytical methods in place to quantitatively evaluate capsid species present during downstream processing.
However, choosing the right technique can be challenging. While the most common techniques are analytical ultracentrifugation (AUC), anion-exchange chromatography (AEX) and capillary electrophoresis, those methods rely on absorbance-based detection, which can be problematic. There’s no reason to not consider native mass spectrometry (MS) to achieve the goal.
In a recent experiment, Thermo Fisher Scientific demonstrated how native MS analysis of AAV capsids allows for accurate assessment of genome packaging efficiency. The study showed how native MS can be used to successfully quantify full and empty AAV capsids.
Read more details in this customer note.